Overview
- Editors:
-
-
John S. Werry
-
University of Auckland, Auckland, New Zealand
-
Michael G. Aman
-
The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columbus, USA
Access this book
Other ways to access
Table of contents (15 chapters)
-
Front Matter
Pages i-xxxi
-
General Principles
-
-
-
- James William Paxton, Michael Dragunow
Pages 23-55
-
-
- Alan J. Zametkin, Emily M. Yamada
Pages 75-97
-
-
- Ronald Schouten, Kenneth S. Duckworth
Pages 161-178
-
- Kelly Botteron, Barbara Geller
Pages 179-201
-
Specific Drugs
-
Front Matter
Pages 203-203
-
- Russell A. Barkley, George J. DuPaul, Anthony Costello
Pages 205-237
-
- John O. Viesselman, Shahnour Yaylayan, Elizabeth B. Weller, Ronald A. Weller
Pages 239-268
-
- Magda Campbell, Nilda M. Gonzalez, Monique Ernst, Raul R. Silva, John S. Werry
Pages 269-296
-
- Alan S. Unis, Jon Mcclellan
Pages 297-319
-
- Richard O. Carpenter, Eileen P. G. Vining
Pages 321-346
-
- Brent Waters, Antony Milch
Pages 347-371
-
-
- John s. Werry, Michael G. Aman
Pages 391-415
-
Back Matter
Pages 417-440
About this book
information. This book aims to do this for practitioners, professionals in health, welfare, and education, and interested laypersons, including parents. This is no easy task, since the levels of technical knowledge vary from that of the special education teacher seeking information about the drugs that many such pupils will be receiving, to that of the modern young child and adolescent psychiatrist whose grasp of the difficult fields of pharmacokinetics (how drugs are absorbed, distributed, and eliminated) and neurotransmitter physiology (via which most psychoactive drugs work) is daunting to the editors, who grew up in the bucolic clinical-empirical era. Inevitably there are sections of the book that will prove too technical for any except the medically qualified, but considerable effort has been applied to make much of the text, especially that discussing the clinical uses and side effects of the drugs, comprehensible to anyone used to getting information by reading. We also take comfort in the fact that many of the major contributions in pediatric psychophar macology have been made by nonmedical professionals, notably psychologists, suggesting that an audience beyond the medically qualified is practicable. One other problem confronted us-whether to organize the book by psycho pathological symptoms (e.g., hyperactivity) and disorders (e.g., autism) or by drugs.
Editors and Affiliations
-
University of Auckland, Auckland, New Zealand
John S. Werry
-
The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columbus, USA
Michael G. Aman
